Skip to main content
OpenTrials
Completed

NCT Number: NCT05790902

COMPARISON OF SILODOSIN AND TAMSULOSIN IN MEDICAL EXPULSIVE THERAPY OF DISTAL URETERIC CALCULI

to compare efficacy and safety of Silodosin and Tamsulosin in Medical expulsive therapy of Distal Ureteric Calculi.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Silodosin, Tamsulosin, Medical Expulsive Therapy, Distal Ureteric Calculi

Age range

18 year–55 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 1

Primary location

AFIU Rawalpindi

Rawalpindi, Punjab Province, 46000, Pakistan

About this study

to compare efficacy and safety of Silodosin and Tamsulosin in Medical expulsive therapy of Distal Ureteric Calculi in our local setup to find out the optimal drug which promptly and quickly cures the disease thus enabling the person to return to routine activity with less adverse effects.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • symptomatic, unilateral, single, uncomplicated Distal Ureteric Calculi of <10 mm in size (on plain CT KUB)

Exclusion criteria

  • solitary kidney, bilateral ureteric stones, UTI, renal impairment, high-grade hydronephrosis (Grades 3 and 4), any history of previous endoscopic or surgical interventions, pregnancy, diabetes mellitus,

Treatment and study plan

Silodosin

Drug

The patients used Silodosin for Medical expulsive therapy of ureteric calculi

Tamsulosin

Drug

The patients used Tamsulosin for Medical expulsive therapy of ureteric calculi

Primary outcomes

  1. Stone clearance rate

    Time frame: upto 4 weeks

    Stone clearance rate

Secondary outcomes

  1. Stone expulsion time

    Time frame: upto 4 weeks

    Stone expulsion time

Sponsors and collaborators

Lead sponsor

Armed Forces Institute of Urology, Rawalpindi

Other

Registry information

Important dates

Study start
2022
Primary completion
2023
Study completion
2023
First posted
Mar 30, 2023
Registry last updated
Mar 30, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.